Jaguar Health Secures $3.448 Million in Bridge Financing

Jaguar Health, Inc. has announced a strategic bridge financing of $3.448 million. The initiative involves investments from CEO Lisa Conte, board members, key executives, and select institutional and accredited investors. The financing, conducted via securities purchase agreements, involves issuing convertible promissory notes with a 6% annual interest, convertible into common stock per investors' discretion. These notes have a three-month maturity under Nasdaq's at-the-market rule.

The raised funds are earmarked for working capital and general corporate purposes. Additionally, the investors will receive unregistered warrants. This private placement, managed by H.C. Wainwright & Co., is expected to close by March 27, 2025, pending customary conditions. The offering remains unregistered under U.S. securities laws, making the resale of shares contingent on specific exemptions.